878372660	878372660	CD	B-NP	O
|	|	NNP	I-NP	O
U	U	NNP	I-NP	O
|	|	VBD	B-VP	O
92462834	92462834	CD	B-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
219540	219540	CD	B-NP	O
|	|	CC	I-NP	O
11/29/2000	11/29/2000	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
CONGESTIVE	CONGESTIVE	NNP	I-NP	I-protein
HEART	HEART	NNP	I-NP	I-protein
FAILURE	FAILURE	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
11/15/2000	11/15/2000	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
6/2/2000	6/2/2000	CD	B-NP	O
SERVICE	SERVICE	NN	I-NP	O
:	:	:	O	O
GENERAL	GENERAL	NNP	B-NP	O
MEDICINE	MEDICINE	NNP	I-NP	O
TEAM	TEAM	NNP	I-NP	O
Fontpor	Fontpor	NNP	I-NP	O
Wood	Wood	NNP	I-NP	O
Vi	Vi	NNP	I-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DIAGNOSES	DIAGNOSES	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

CONGESTIVE	CONGESTIVE	NNP	B-NP	O
HEART	HEART	NNP	I-NP	O
FAILURE	FAILURE	NNP	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

REACTIVE	REACTIVE	NNP	B-NP	O
AIRWAY	AIRWAY	NNP	I-NP	O
DISEASE	DISEASE	NNP	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

HYPERTENSION	HYPERTENSION	NN	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

MORBID	MORBID	NNP	B-NP	O
OBESITY	OBESITY	NNP	I-NP	O
.	.	.	O	O

BRIEF	BRIEF	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
60-year-old	60-year-old	JJ	I-NP	O
African-American	African-American	JJ	I-NP	O
female	female	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
recent	recent	JJ	I-NP	O
,	,	,	I-NP	O
eleven-day	eleven-day	JJ	I-NP	O
hospitalization	hospitalization	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
Brentcal	Brentcal	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
congestive	congestive	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
flare	flare	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
presents	present	VBZ	B-VP	O
now	now	RB	B-ADVP	O
with	with	IN	B-PP	O
two	two	CD	B-NP	O
days	day	NNS	I-NP	O
of	of	IN	B-PP	O
progressively	progressively	RB	B-VP	O
worsening	worsen	VBG	I-VP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
at	at	IN	B-PP	O
rehabilitation	rehabilitation	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
presented	present	VBN	B-VP	O
initially	initially	RB	B-ADVP	O
with	with	IN	B-PP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
and	and	CC	I-NP	O
CHF	CHF	NN	I-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
was	be	VBD	B-VP	O
ruled	rule	VBN	I-VP	O
out	out	RP	B-PRT	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
myocardial	myocardial	JJ	I-NP	O
infarction	infarction	NN	I-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
early	early	JJ	B-NP	O
October	October	NNP	I-NP	O
.	.	.	O	O

An	An	DT	B-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
then	then	RB	B-ADVP	O
revealed	reveal	VBD	B-VP	O
mild	mild	JJ	B-ADJP	O
to	to	TO	B-PP	O
moderate	moderate	JJ	B-NP	O
left	left	JJ	I-NP	O
ventricular	ventricular	JJ	I-NP	O
dysfunction	dysfunction	NN	I-NP	O
and	and	CC	O	O
abnormal	abnormal	JJ	B-NP	O
septal	septal	JJ	I-NP	O
motion	motion	NN	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
septal	septal	JJ	B-NP	O
apical	apical	JJ	I-NP	O
hypokinesis	hypokinesis	NN	I-NP	O
and	and	CC	O	O
minimal	minimal	JJ	B-NP	O
mitral	mitral	JJ	I-NP	O
regurgitation	regurgitation	NN	I-NP	O
.	.	.	O	O

An	An	DT	B-NP	O
exercise	exercise	NN	I-NP	O
treadmill	treadmill	NN	I-NP	O
test	test	NN	I-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
was	be	VBD	B-VP	O
without	without	IN	B-PP	O
ischemia	ischemia	NN	B-NP	O
,	,	,	O	O
though	though	IN	B-SBAR	O
her	her	PRP$	B-NP	O
target	target	NN	I-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
achieved	achieve	VBN	I-VP	O
.	.	.	O	O

During	During	IN	B-PP	O
the	the	DT	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
slowly	slowly	RB	I-VP	O
diuresed	diurese	VBN	I-VP	O
and	and	CC	O	O
then	then	RB	B-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-PP	O
rehabilitation	rehabilitation	NN	B-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
rehabilitation	rehabilitation	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
chest-pain-free	chest-pain-free	JJ	B-ADJP	O
,	,	,	O	O
but	but	CC	O	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
increasing	increase	VBG	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
and	and	CC	I-NP	O
wheezing	wheezing	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
department	department	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
in	in	IN	B-PP	O
congestive	congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
by	by	IN	B-PP	O
chest	chest	NN	B-NP	O
x-ray	x-ray	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
oxygen	oxygen	NN	I-NP	O
saturations	saturation	NNS	I-NP	O
were	be	VBD	B-VP	O
93	93	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
2	2	CD	B-NP	O
liters	liter	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
albuterol	albuterol	NN	B-NP	O
and	and	CC	I-NP	O
Atrovent	Atrovent	NN	I-NP	O
nebulizers	nebulizer	NNS	I-NP	O
and	and	CC	O	O
IV	IV	CD	B-NP	O
Solu-Medrol	Solu-Medrol	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
given	give	VBN	I-VP	O
a	a	DT	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
120	120	CD	B-NP	O
mg	mg	NN	I-NP	O
of	of	IN	B-PP	O
IV	IV	CD	B-NP	O
Lasix	Lasix	NNP	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Please	Please	NNP	B-NP	O
see	see	VB	B-VP	O
the	the	DT	B-NP	O
Problem	Problem	NNP	I-NP	O
List	List	NNP	I-NP	O
.	.	.	O	O

PAST	PAST	NN	B-NP	O
SURGICAL	SURGICAL	NN	I-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
the	the	DT	B-NP	O
following	follow	VBG	I-NP	O
surgeries	surgery	NNS	I-NP	O
:	:	:	O	O
-LRB-	-LRB-	NN	B-NP	O
1	1	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
A	A	NN	I-NP	O
cholecystectomy	cholecystectomy	NN	I-NP	O
;	;	:	O	O
-LRB-	-LRB-	SYM	B-NP	O
2	2	CD	I-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
Two	Two	CD	I-NP	O
Caesarean	Caesarean	JJ	I-NP	O
sections	section	NNS	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
Ventolin	Ventolin	NN	B-NP	O
two	two	CD	B-NP	O
puffs	puff	NNS	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.i.d.	q.i.d.	FW	I-ADVP	O
,	,	,	O	O
Azmacort	Azmacort	NNP	B-NP	O
four	four	CD	I-NP	O
puffs	puff	NNS	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
Rhinocort	Rhinocort	NNP	B-NP	O
two	two	CD	B-NP	O
puffs	puff	NNS	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
enteric-coated	enteric-coated	JJ	B-NP	O
aspirin	aspirin	NN	I-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
atenolol	atenolol	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
Lasix	Lasix	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
Motrin	Motrin	NNP	B-NP	O
800	800	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
Isordil	Isordil	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
Claritin	Claritin	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
Cozaar	Cozaar	NNP	B-NP	O
75	75	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
Pepcid	Pepcid	NNP	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
simvastatin	simvastatin	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
nitroglycerin	nitroglycerin	NN	B-NP	O
sublingually	sublingually	RB	B-NP	O
p.r.n.	p.r.n.	FW	I-NP	O
LISTED	LISTED	NNP	I-NP	O
ALLERGIES	ALLERGIES	NNPS	I-NP	O
:	:	:	O	O
Lisinopril	Lisinopril	NNP	B-NP	O
gives	give	VBZ	B-VP	O
her	her	PRP	B-NP	O
a	a	DT	B-NP	O
cough	cough	NN	I-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
tobacco	tobacco	NN	I-NP	O
or	or	CC	I-NP	O
alcohol	alcohol	NN	I-NP	O
use	use	NN	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
IV	IV	CD	I-NP	O
drug	drug	NN	I-NP	O
abuse	abuse	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
works	work	VBZ	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
Chand	Chand	NNP	I-NP	O
O	O	NNP	I-NP	O
Rock	Rock	NNP	I-NP	O
,	,	,	O	O
Virginia	Virginia	NNP	B-NP	O
48456	48456	CD	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
Ham	Ham	NNP	I-NP	O
Greatsilove	Greatsilove	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
vital	vital	JJ	I-NP	O
signs	sign	NNS	I-NP	O
include	include	VBP	B-VP	O
the	the	DT	B-NP	O
following	following	NN	I-NP	O
:	:	:	O	O
the	the	DT	B-NP	O
temperature	temperature	NN	I-NP	O
is	be	VBZ	B-VP	O
98.0	98.0	CD	B-NP	O
degrees	degree	NNS	I-NP	O
F.	F.	NNP	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
pulse	pulse	NN	I-NP	O
87	87	CD	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
180/110	180/110	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
respirations	respiration	NNS	I-NP	O
24	24	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
oxygen	oxygen	NN	I-NP	O
saturation	saturation	NN	I-NP	O
is	be	VBZ	B-VP	O
92	92	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
2	2	CD	B-NP	O
liters	liter	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
general	general	JJ	B-ADJP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
morbidly	morbidly	RB	I-NP	O
obese	obese	JJ	I-NP	O
female	female	NN	I-NP	O
in	in	IN	B-PP	O
mild	mild	JJ	B-ADJP	O
to	to	TO	B-PP	O
moderate	moderate	JJ	B-NP	O
distress	distress	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
neck	neck	NN	I-NP	O
is	be	VBZ	B-VP	O
supple	supple	NN	B-NP	O
,	,	,	O	O
without	without	IN	B-PP	O
bruits	bruit	NNS	B-NP	O
;	;	:	O	O
the	the	DT	B-NP	O
jugular	jugular	JJ	I-NP	O
venous	venous	JJ	I-NP	O
pressure	pressure	NN	I-NP	O
can	can	MD	B-VP	O
not	not	RB	I-VP	O
be	be	VB	I-VP	O
assessed	assess	VBN	I-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
body	body	NN	I-NP	O
habitus	habitus	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
cardiovascular	cardiovascular	JJ	I-NP	O
examination	examination	NN	I-NP	O
shows	show	VBZ	B-VP	O
a	a	DT	B-NP	O
regular	regular	JJ	I-NP	O
rate	rate	NN	I-NP	O
and	and	CC	I-NP	O
rhythm	rhythm	NN	I-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
S1	S1	NN	I-NP	B-protein
,	,	,	O	O
an	an	DT	B-NP	O
S2	S2	NN	I-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
an	an	DT	B-NP	O
S3	S3	NN	I-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
2/6	2/6	CD	I-NP	O
systolic	systolic	JJ	I-NP	O
ejection	ejection	NN	I-NP	O
murmur	murmur	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
upper	upper	JJ	I-NP	O
sternal	sternal	JJ	I-NP	O
border	border	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
2/6	2/6	CD	I-NP	O
murmur	murmur	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
upper	upper	JJ	I-NP	O
sternal	sternal	JJ	I-NP	O
border	border	NN	I-NP	O
.	.	.	O	O

Examination	Examination	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
lungs	lung	NNS	I-NP	O
is	be	VBZ	B-VP	O
significant	significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
rales	rale	NNS	B-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
in	in	IN	B-PP	O
one-third	one-third	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
lung	lung	NN	I-NP	O
fields	field	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
has	have	VBZ	B-VP	O
inspiratory	inspiratory	JJ	B-NP	O
and	and	CC	I-NP	O
expiratory	expiratory	JJ	I-NP	O
wheezing	wheezing	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
prolonged	prolonged	JJ	I-NP	O
expiratory	expiratory	JJ	I-NP	O
phase	phase	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
abdomen	abdomen	NN	I-NP	O
is	be	VBZ	B-VP	O
soft	soft	JJ	B-ADJP	O
,	,	,	O	O
non-tender	non-tender	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
non-distended	non-distended	JJ	B-ADJP	O
,	,	,	O	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
masses	mass	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
extremities	extremity	NNS	I-NP	O
show	show	VBP	B-VP	O
2	2	CD	B-NP	O
+	+	SYM	B-NP	O
pitting	pit	VBG	B-VP	O
edema	edema	NN	B-NP	O
in	in	IN	B-PP	O
both	both	CC	B-NP	O
lower	low	JJR	I-NP	O
extremities	extremity	NNS	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
pulses	pulse	NNS	I-NP	O
are	be	VBP	B-VP	O
2	2	CD	B-NP	O
+	+	SYM	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
dorsalis	dorsalis	NN	I-NP	O
pedis	pedis	NN	I-NP	O
and	and	CC	O	O
posterior	posterior	JJ	B-NP	O
tibial	tibial	JJ	I-NP	O
arteries	artery	NNS	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
neurological	neurological	JJ	B-NP	O
examination	examination	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
alert	alert	JJ	B-ADJP	O
and	and	CC	O	O
oriented	orient	VBN	B-VP	O
times	time	NNS	B-NP	O
four	four	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
neurologic	neurologic	JJ	I-NP	O
examination	examination	NN	I-NP	O
is	be	VBZ	B-VP	O
otherwise	otherwise	RB	B-ADJP	O
non-focal	non-focal	JJ	I-ADJP	O
.	.	.	O	O

DATA	DATA	NN	B-NP	O
BASE	BASE	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
admission	admission	NN	I-NP	O
chest	chest	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
showed	show	VBD	B-VP	O
moderate	moderate	JJ	B-NP	O
congestive	congestive	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
with	with	IN	B-PP	O
moderate	moderate	JJ	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
edema	edema	NN	I-NP	O
but	but	CC	O	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
infiltrate	infiltrate	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
EKG	EKG	NNP	I-NP	O
revealed	reveal	VBD	B-VP	O
a	a	DT	B-NP	O
normal	normal	JJ	I-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
60	60	CD	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
normal	normal	JJ	I-NP	O
axis	axis	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
no	no	DT	B-NP	O
ST-T	ST-T	NN	I-NP	O
wave	wave	NN	I-NP	O
changes	change	NNS	I-NP	O
when	when	WRB	B-ADVP	O
compared	compare	VBN	B-VP	O
to	to	TO	B-PP	O
prior	prior	JJ	B-NP	O
EKGs	EKG	NNS	I-NP	O
from	from	IN	B-PP	O
October	October	NNP	B-NP	O
2000	2000	CD	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
admission	admission	NN	I-NP	O
laboratory	laboratory	NN	I-NP	O
studies	study	NNS	I-NP	O
were	be	VBD	B-VP	O
as	as	IN	B-SBAR	O
follows	follow	VBZ	B-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
sodium	sodium	NN	I-NP	O
was	be	VBD	B-VP	O
140	140	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
potassium	potassium	NN	I-NP	O
4.0	4.0	CD	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
chloride	chloride	NN	I-NP	O
99	99	CD	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
CO2	CO2	NN	I-NP	O
39	39	CD	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
BUN	BUN	NN	I-NP	B-DNA
23	23	CD	I-NP	I-DNA
,	,	,	O	O
the	the	DT	B-NP	O
creatinine	creatinine	NN	I-NP	B-protein
0.9	0.9	CD	I-NP	I-protein
,	,	,	O	O
the	the	DT	B-NP	O
glucose	glucose	NN	I-NP	O
78	78	CD	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
CK	CK	NN	I-NP	B-DNA
114	114	CD	I-NP	I-DNA
,	,	,	O	O
the	the	DT	B-NP	O
troponin	troponin	NN	I-NP	B-protein
0.00	0.00	CD	I-NP	I-protein
.	.	.	O	O

The	The	DT	B-NP	O
white	white	JJ	I-NP	O
count	count	NN	I-NP	O
was	be	VBD	B-VP	O
8	8	CD	B-NP	O
,	,	,	I-NP	O
200	200	CD	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
44	44	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
platelets	platelet	NNS	I-NP	B-cell_type
315	315	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
PT	PT	NN	I-NP	B-protein
was	be	VBD	B-VP	I-protein
11.8	11.8	CD	B-NP	I-protein
,	,	,	O	O
the	the	DT	B-NP	O
PTT	PTT	NN	I-NP	B-DNA
23.1	23.1	CD	I-NP	I-DNA
.	.	.	O	O

The	The	DT	B-NP	O
cholesterol	cholesterol	NN	I-NP	O
level	level	NN	I-NP	O
was	be	VBD	B-VP	O
206	206	CD	B-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
By	By	IN	B-PP	O
problems	problem	NNS	B-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

CARDIOVASCULAR	CARDIOVASCULAR	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
re-admitted	re-admitted	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Wakeview	Wakeview	NNP	I-NP	O
Hosp	Hosp	NNP	I-NP	O
Of	Of	NNP	I-NP	O
Valley	Valley	NNP	I-NP	O
with	with	IN	B-PP	O
worsening	worsen	VBG	B-VP	O
congestive	congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
Lasix	Lasix	NNP	B-NP	O
of	of	IN	B-PP	O
40	40	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
received	receive	VBD	B-VP	O
120	120	CD	B-NP	O
mg	mg	NN	I-NP	O
IV	IV	CD	B-NP	O
Lasix	Lasix	NNP	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
department	department	NN	I-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
diuresis	diuresis	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
with	with	IN	B-PP	O
aggressive	aggressive	JJ	B-NP	O
intravenous	intravenous	JJ	I-NP	O
Lasix	Lasix	NN	I-NP	O
until	until	IN	B-PP	O
two	two	CD	B-NP	O
days	day	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
,	,	,	O	O
when	when	WRB	B-ADVP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
switched	switch	VBN	I-VP	O
to	to	TO	I-VP	O
p.o.	p.o.	VB	I-VP	O
Lasix	Lasix	NNP	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
initially	initially	RB	B-ADVP	O
on	on	IN	B-PP	O
120	120	CD	B-NP	O
mg	mg	NN	I-NP	O
of	of	IN	B-PP	O
IV	IV	CD	B-NP	O
Lasix	Lasix	NNP	I-NP	O
once	once	RB	B-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
diuresis	diuresis	NN	I-NP	O
of	of	IN	B-PP	O
1-2	1-2	CD	B-NP	O
liters	liter	NNS	I-NP	O
every	every	DT	B-NP	O
twenty-four-hour	twenty-four-hour	JJ	I-NP	O
period	period	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
ruled	rule	VBN	I-VP	O
out	out	RP	B-PRT	O
for	for	IN	B-PP	O
myocardial	myocardial	JJ	B-NP	O
infarction	infarction	NN	I-NP	O
by	by	IN	B-PP	O
serial	serial	JJ	B-NP	B-protein
enzymes	enzyme	NNS	I-NP	I-protein
and	and	CC	I-NP	O
EKGs	EKG	NNS	I-NP	B-protein
.	.	.	O	O

The	The	DT	B-NP	O
decision	decision	NN	I-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
made	make	VBN	I-VP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	O
hospitalization	hospitalization	NN	I-NP	O
to	to	TO	B-VP	O
manage	manage	VB	I-VP	O
her	her	PRP$	B-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
medically	medically	RB	B-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
desire	desire	VB	I-VP	O
cardiac	cardiac	JJ	B-NP	O
catheterization	catheterization	NN	I-NP	O
at	at	IN	B-PP	O
this	this	DT	B-NP	O
point	point	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
eventually	eventually	RB	I-VP	O
switched	switch	VBN	I-VP	O
to	to	TO	B-PP	O
oral	oral	JJ	B-NP	O
Lasix	Lasix	NN	I-NP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
60	60	CD	B-NP	O
mg	mg	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

RESPIRATORY	RESPIRATORY	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
for	for	IN	B-PP	O
congestive	congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
but	but	CC	B-CONJP	O
also	also	RB	I-CONJP	O
had	have	VBD	B-VP	O
evidence	evidence	NN	B-NP	O
of	of	IN	B-PP	O
reactive	reactive	JJ	B-NP	O
airway	airway	NN	I-NP	O
disease	disease	NN	I-NP	O
on	on	IN	B-PP	O
clinical	clinical	JJ	B-NP	O
examination	examination	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
profound	profound	JJ	B-NP	O
inspiratory	inspiratory	JJ	I-NP	O
and	and	CC	I-NP	O
expiratory	expiratory	JJ	I-NP	O
wheezes	wheeze	NNS	I-NP	O
and	and	CC	O	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
.	.	.	O	O

Due	Due	JJ	B-PP	O
to	to	TO	I-PP	O
the	the	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
reactive	reactive	JJ	B-NP	O
airway	airway	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
intravenous	intravenous	JJ	B-NP	O
Solu-Medrol	Solu-Medrol	NN	I-NP	O
,	,	,	O	O
albuterol	albuterol	NN	B-NP	O
,	,	,	O	O
Atrovent	Atrovent	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Serevent	Serevent	NNP	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
supplemental	supplemental	JJ	B-NP	O
O2	O2	NN	I-NP	O
to	to	TO	B-VP	O
maintain	maintain	VB	I-VP	O
her	her	PRP$	B-NP	O
oxygen	oxygen	NN	I-NP	O
saturations	saturation	NNS	I-NP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
93	93	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
her	her	PRP	B-NP	O
IV	IV	CD	I-NP	O
steroids	steroid	NNS	I-NP	O
throughout	throughout	IN	B-PP	O
the	the	DT	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
these	these	DT	B-NP	O
were	be	VBD	B-VP	O
eventually	eventually	RB	I-VP	O
switched	switch	VBN	I-VP	O
to	to	TO	B-PP	O
p.o.	p.o.	FW	B-NP	O
prednisone	prednisone	NN	I-NP	O
near	near	IN	B-PP	O
the	the	DT	B-NP	O
end	end	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
and	and	CC	O	O
were	be	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
tapered	taper	VBN	I-VP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
basis	basis	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
resolved	resolve	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

FLUIDS	FLUIDS	NNS	B-NP	O
AND	AND	CC	I-NP	O
ELECTROLYTES	ELECTROLYTES	NNS	I-NP	O
.	.	.	O	O

Due	Due	JJ	B-PP	O
to	to	TO	I-PP	O
the	the	DT	B-NP	O
aggressive	aggressive	JJ	I-NP	O
diuresis	diuresis	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
developed	develop	VBD	B-VP	O
a	a	DT	B-NP	O
contraction	contraction	NN	I-NP	O
alkalosis	alkalosis	NN	I-NP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
hospitalization	hospitalization	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
bicarbonate	bicarbonate	NN	I-NP	O
rose	rise	VBD	B-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
level	level	NN	I-NP	O
of	of	IN	B-PP	O
43	43	CD	B-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
BUN	BUN	NN	I-NP	O
of	of	IN	B-PP	O
34	34	CD	B-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
diuresis	diuresis	NN	I-NP	O
was	be	VBD	B-VP	O
withdrawn	withdraw	VBN	I-VP	O
slightly	slightly	RB	B-ADVP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
electrolytes	electrolyte	NNS	I-NP	O
normalized	normalize	VBD	B-VP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Albuterol	Albuterol	NNP	B-NP	O
inhaler	inhaler	IN	B-PP	O
two	two	CD	B-NP	O
puffs	puff	NNS	I-NP	O
q.i.d.	q.i.d.	RB	B-ADVP	O
,	,	,	O	O
enteric-coated	enteric-coated	JJ	B-NP	O
aspirin	aspirin	NN	I-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
Lasix	Lasix	NNP	B-NP	O
60	60	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
Robitussin	Robitussin	NN	B-NP	O
with	with	IN	B-PP	O
codeine	codeine	NN	B-NP	O
5	5	CD	I-NP	O
ml	ml	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.	q.	NN	I-NP	O
4h	4h	NN	I-NP	O
.	.	.	O	O

,	,	,	O	O
Atrovent	Atrovent	NNP	B-NP	O
inhaler	inhaler	IN	B-PP	O
two	two	CD	B-NP	O
puffs	puff	NNS	I-NP	O
inhaled	inhale	VBD	B-VP	O
q.i.d.	q.i.d.	NN	B-NP	O
,	,	,	O	O
Isordil	Isordil	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
Lopressor	Lopressor	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
nitroglycerin	nitroglycerin	NN	B-NP	O
0.4	0.4	CD	I-NP	O
mg	mg	NN	I-NP	O
sublingually	sublingually	RB	B-ADVP	O
p.r.n.	p.r.n.	RB	I-ADVP	O
,	,	,	O	O
Zantac	Zantac	NN	B-NP	O
150	150	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
Zocor	Zocor	NNP	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
,	,	,	O	O
Norvasc	Norvasc	NNP	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
Serevent	Serevent	NNP	B-NP	O
two	two	CD	I-NP	O
puffs	puff	NNS	I-NP	O
inhaled	inhale	VBD	B-VP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
Claritin	Claritin	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
Flovent	Flovent	NNP	B-NP	O
220	220	CD	I-NP	O
micrograms	microgram	NNS	I-NP	O
inhaled	inhale	VBD	B-VP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
Cozaar	Cozaar	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
prednisone	prednisone	NN	I-NP	O
taper	taper	NN	I-NP	O
with	with	IN	B-PP	O
60	60	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
for	for	IN	B-PP	O
three	three	CD	B-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
50	50	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
for	for	IN	B-PP	O
three	three	CD	B-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
40	40	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
for	for	IN	B-PP	O
three	three	CD	B-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
30	30	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
for	for	IN	B-PP	O
three	three	CD	B-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
20	20	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
for	for	IN	B-PP	O
three	three	CD	B-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
10	10	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
for	for	IN	B-PP	O
three	three	CD	B-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Improved	Improve	VBN	B-VP	O
.	.	.	O	O

DISPOSITION	DISPOSITION	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
home	home	NN	B-ADVP	O
.	.	.	O	O

Dictated	Dictate	VBN	B-VP	O
By	By	IN	B-PP	O
:	:	:	O	O
CARMEN	CARMEN	NNP	B-NP	O
O.	O.	NNP	I-NP	O
MONTALGO	MONTALGO	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
AO20	AO20	NNP	I-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
CASEY	CASEY	NNP	B-NP	O
M.	M.	NNP	I-NP	O
MCGOON	MCGOON	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
FS8	FS8	NNP	I-NP	O
CM264/7085	CM264/7085	NNP	I-NP	O
Batch	Batch	NNP	I-NP	O
:	:	:	O	O
11834	11834	CD	B-NP	O
Index	Index	NNP	I-NP	O
No	No	NNP	I-NP	O
.	.	.	O	O

GRKJ7234J1	GRKJ7234J1	NN	B-NP	O
D	D	NN	I-NP	O
:	:	:	O	O
3/13	3/13	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
6/3	6/3	CD	B-NP	O

